key: cord-1031699-dvfeosgt authors: Cao, Yinghao; Liu, Xiaoling; Xiong, Lijuan; Cai, Kailin title: Imaging and clinical features of patients with 2019 novel coronavirus SARS‐CoV‐2: A systematic review and meta‐analysis date: 2020-04-10 journal: J Med Virol DOI: 10.1002/jmv.25822 sha: c94e02dd9438b99a09514ef3b39480e1887eb657 doc_id: 1031699 cord_uid: dvfeosgt BACKGROUND: Currently, the epidemic of coronavirus disease 2019 (COVID‐19) has begun to spread worldwide. We aim to explore reliable evidence for the diagnosis and treatment of the COVID‐19 by analyzing all the published studies by Chinese scholars on the clinical and imaging features in novel coronavirus pneumonia caused by SARS‐CoV‐2. METHODS: We searched five medical databases including two Chinese and three English databases for all published articles on COVID‐19 since the outbreak. A random‐effects model was designed, and the imaging and clinical data from all studies were collected for meta‐analysis. RESULTS: Overall, 31 articles and 46 959 patients were included, including 10 English articles and 21 Chinese articles. The results of meta‐analysis showed that the most common clinical manifestations were fever (87.3%; 0.838‐0.909), cough (58.1%; 0.502‐0.660), dyspnea (38.3%; 0.246‐0.520), muscle soreness or fatigue (35.5%; 0.253‐0.456), and chest distress (31.2%; −0.024 to 0.648). The main imaging findings were bilateral pneumonia (75.7%; 0.639‐0.871) and ground‐glass opacification (69.9%; 0.602‐0.796). Among the patients, the incidence that required intensive care unit (ICU) was (29.3%; 0.190‐0.395), the incidence with acute respiratory distress syndrome was (28.8%; 0.147‐0.429), the incidence with multiple organ dysfunction syndrome was (8.5%; −0.008 to 0.179), and the case fatality rate of patients with COVID‐19 was (6.8%; 0.044‐0.093). CONCLUSION: COVID‐19 is a new clinical infectious disease that mainly causes bilateral pneumonia and lung function deteriorates rapidly. Nearly a third of patients need to be admitted to the ICU, and patients are likely to present respiratory failure or even death. The 2019 novel coronavirus pneumonia (NCP) initially broke out in China, especially in Hubei province. The NCP is caused by a new coronavirus (SARS-COV-2) of the Sarbe virus subgenus, a member of orthocoronavirus subfamily. 1 SARS-COV-2 is a member of the coronavirus family along with SARS-CoV and MERS-CoV. With the deepening of research, more and more evidence show that its transmission channels are diversified, and its transmission speed and infectivity are stronger than SARS-CoV and MERS-CoV. [2] [3] [4] Since the outbreak of the epidemic, China has taken active prevention and control measures and achieved good results, but, recently, the epidemic situation abroad has begun to develop into an uncontrollable situation. As of 28 February 2020, the epidemic of NCP has affected six continents, and the epidemic situation in South Korea, Italy, Japan, and other countries is extremely serious. On 29 February, the "China-WHO NCP (COVID-19) Joint Inspection Report" stated that the NCP is almost susceptible to everyone on the same day. On 11 March, the WHO declared the SARS-CoV-2 outbreak as pandemic. Currently, published studies and case reports indicate that patients with NCP have very different clinical manifestations, laboratory tests, and imaging tests, making clinical diagnosis and treatment limited. Therefore, it is urgent to improve the understanding of the clinical characteristics of patients with NCP to further guide clinical and scientific research through evidence-based medicine. Exclusive criteria are as follows: (a) the type of study is case report, review, and so forth; (b) repeated research; and (c) lack of the above case data. The titles and abstracts of all retrieved references were independently reviewed by two investigators, and if there was any ambiguity in the search process, the decision was made by a third investigator. (a) The The statistical software Stata version 14.0 and Open Meta-Analyst were used for meta-analysis of single-arm studies. We first unified all units of variables and, then, expressed classified variables as percentages and expressed continuous variables as mean ± standard deviation. The combined prevalence and 95% CI were calculated using a random-effects model. We performed the Egger test to assess publication bias in all literature works, and P < .05 was considered as publication bias. Table 1 . Publication bias was assessed with a funnel plot for the standard error by logit event, with no evidence of bias. Additionally, the Egger test (P = .091) suggested that there was no notable evidence of publication bias. The mean age of the patients with SARS-COV-2 infection was 46.62 (95% CI, 31.710-61.531) and 55.6% (95% CI, 0.530-0.602) were male. The incidence of fever was 87.3% (0.838-0.909), that of cough was 58.1% (0.502-0.660), that of sore throat was 12% (0.062-0.177), that of expectoration was 29.4% (0.171-0.417), that of chest distress was 31.2% (−0.024 to 0.648), that of muscle soreness or fatigue was 35.5% (0.253-0.456), that of headache was 9.4% (0.063-0.126), that of diarrhea was 6.8% (0.044-0.092), and that of dyspnea was 38.3% (0.246-0.520) ( Table 3 and Figure 4 ). The laboratory findings showed leukocytosis in 11.0% (0.070-0.150), leukopenia in 36.9% (0.146-0.593), lymphocytopenia in 57.4% Table 5 and Figure 6 ). Among the infected patients, severe cases who required intensive care unit (ICU) were 29.3% (0.190-0.395), and the incidence of acute respiratory distress syndrome (ARDS) was F I G U R E 1 Diagram of documents retrieval CAO ET AL. The results of this study showed that fever (87.3%) and cough The "three early" principle (early detection, early diagnosis, and F I G U R E 7 The forest plots of the incidence of complication. A, acute respiratory distress syndrome; (B) acute cardiac injury; (C) acute renal injury; (D) shock; (E) multiple organ dysfunction syndrome; (F) mortality public health emergencies of international concern. Certainly, prevention of imported cases is also extremely important. 45 Particularly, in some densely populated markets, stations, large ports, and other places, protective deployment measures should be strengthened to ensure that protective equipment, drugs, medical supplies, and so on are sufficient. 46 National public health capabilities and infrastructure remain at the core of global health security, as they are the first line of defense for infectious disease emergencies. 47 The International Health Organization, all countries, and all humanity need to pay great attention to SARS-COV-2. This meta-analysis, with large enough sample size, relatively COVID-19 is a new clinical infectious disease, which mainly causes bilateral pneumonia and lung function deteriorates rapidly. Nearly a third of patients need to be admitted to the ICU, and patients are likely to present respiratory failure or even death. We are grateful to all the medical staff who worked on the front line to fight the epidemic and even gave their precious lives. This study was supported by grants from the Science and Technology Depart- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia A pneumonia outbreak associated with a new coronavirus of probable bat origin Pathological findings of COVID-19 associated with acute respiratory distress syndrome Institute of Health Economics. Quality Appraisal of Case Series Studies Checklist Clinical features of patients infected with 2019 novel coronavirus in Wuhan Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study CT imaging features of 2019 novel coronavirus (2019-nCoV) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China Computed tomography features of patients with novel coronavirus pneumonia Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury (Chinese) CT features of patients with imported 2019-nCoV-pneumonia Preliminary explore on CT characteristics of coronavirus disease 2019 (COVID-19) Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China The epidemiological and clinical characteristics of 2019 novel coronavirus infection in Changsha Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing Analysis of CT features of 15 children with 2019 novel coronavirus infection Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China Chest CT performance and clinical characteristics of coronavirus disease 2019 (COVID-19) Clinical and epidemiological characteristics of 26 patients dia gnosed with novel coronavirus pneumonia CT characteristic appearances of patients with novel coronavirus pneumonia Retrospective analysis of COVID-19 patients with different clinical subtypes CT findings in 2019 novel coronavirus disease (COVID-19) patients Application of chest CT examination in screening of patients with novel coronavirus pneumonia Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study CT manifestations and dynamic changes of coronavirus disease 2019 Clinical diagnosis and treatment of critical patients with novel coronavirus pneumonia (report of 12 cases) Analysis of clinical and imaging features of novel coronavirus pneumonia in Chongqing traditional Chinese medicine system Clinical characteristics and CT signs of coronavirus disease 2019 (COVID-19) in the elderly Clinical characteristics of coronavirus disease 2019 in China Chest CT features of COVID-19 Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine. An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19) Systematic solution of new coronavirus pneumonia in dead cadavers Study on the mechanism of liver enzyme abnormality in pneumonia infected by novel coronavirus Structure, function, and evolution of coronavirus spike proteins The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex A novel coronavirus from patients with pneumonia in China Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases Risk assessment of novel coronavirus COVID-19 outbreaks outside China Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study The neglected dimension of global security-a framework for countering infectious-disease crises Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis The authors declare that there are no conflict of interests. http://orcid.org/0000-0002-2572-0907